EX-32 7 ex_500918.htm EXHIBIT 32 ex_285368.htm

 

Exhibit 32

 

Section 1350 Certifications

 

Pursuant to 18 U.S.C. § 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of Perspective Therapeutics, Inc., a Delaware corporation (the Company), hereby certify that:

 

To my knowledge, the Transition Report on Form 10-KT of the Company for the period ended December 31, 2022 (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: May 1, 2023

 

 

/s/ Johan (Thijs) Spoor

 

Johan (Thijs) Spoor

 

Chief Executive Officer

 

(Principal Executive Officer)

 

 Dated: May 1, 2023

 

 

/s/ Jonathan Hunt

 

Jonathan Hunt

 

Chief Financial Officer

 

 (Co-Principal Financial Officer)

 

Dated: May 1, 2023

 

 

/s/ Mark J. Austin

 

Mark J. Austin

 

Vice President of Finance and Corporate Controller, Corporate Secretary

 

 (Co-Principal Financial and Principal Accounting Officer)